Pediatric Clinical Trials: Special Considerations and Requirements, Attend the March 14th WEB Session

3/10/2016

Date: March 14, 2016

Time: 1 p.m. – 2:30 p.m. EDT

Duration: 90 Minutes – Online

Sponsored by Life Science Training Institute

For more information or to sign-up visit this link: http://www.lifesciencetraininginstitute.com/doc/pediatric-clinical-trials-special-considerations-and-requirements-0001

Description:

Pediatric clinical trials present unique challenges for monitors and coordinators alike. Minors, as a vulnerable population, require a variety of regulatory protections to be incorporated as part of the study’s design, recruitment strategies, and monitoring plan. In this session a variety of strategies to ensure success when enrolling pediatric populations will be discussed.

This session will use a 3-prong approach evaluating historical, scientific, and regulatory information to help better understand the special considerations encountered when enrolling minors in a study. 

A true case study will be used to illustrate the difference between what actually happens and what should happen.

Take home benefits from this session will include:

     Understanding of the considerations in protocol design when developing a pediatric clinical trial.

     Understanding of the IRB review processes in relation to pediatric populations.

     Knowledge of different enrollment strategies to use when involving pediatric populations in a study.

For more info contact Chuck charlessather@clinicalpathwaysresearch.com or SAM at samsather@clinicalpathwaysresearch.com.

Feel free to pass this on.

Thank you!